Jefferies Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Jefferies Group’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-20,664	Closed	-$244K	–	2996
2017 Q3	$244K	Buy	+20,664	New	+$232K	﹤0.01%	1982
2017 Q2	–	Sell	-21,590	Closed	-$237K	–	2797
2017 Q1	$237K	Sell	21,590 -33,110	-61%	-$384K	﹤0.01%	1944
2016 Q4	$741K	Buy	+54,700	New	+$763K	﹤0.01%	1430
2015 Q4	–	Sell	-25,000	Closed	-$497K	–	2724
2015 Q3	$497K	Buy	+25,000	New	+$573K	﹤0.01%	1514
2015 Q2	–	Sell	-60,054	Closed	-$935K	–	3608
2015 Q1	$935K	Buy	+60,054	New	+$931K	0.01%	1084

Other funds holding SCMP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Jefferies Group's SCMP Position: Q4 2017 in Review

Jefferies Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2017, closing a stake of 20,664 shares — an estimated $244K sold.

Jefferies Group first reported a position in SCMP in Q1 2015 and held it in 5 quarters. The position peaked at $935K in Q1 2015. 188 funds tracked by Wall St. Rank hold SCMP as of Q4 2017.

Jefferies Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
Jefferies Group sold 20,664 Sucampo Pharmaceuticals, Inc. shares in Q4 2017, an estimated $244K.
Jefferies Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2015 and held it in 5 quarters.
Jefferies Group's Sucampo Pharmaceuticals, Inc. position peaked at $935K in Q1 2015.
188 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2017.

Based on Jefferies Group's 13F filing for Q4 2017, filed 14 Feb 2018.